Critical medicine shortage – Palexia IR tapentadol 50mg tablet
Supply of one formulation of tapentadol tablets has been interrupted.
The college has received a notification from the TGA of a shortage of PALEXIA IR tapentadol (as hydrochloride) 50 mg tablet blister pack (ARTG 165310). Other PALEXIA tablet products are not currently affected.
Seqirus is working to expedite the next shipment to resolve the supply interruption by 2 December, however we will be alert to any further supply interruption into the new year.
Generic forms of this product were added to the Australian Register of Therapeutic Goods (ARTG) earlier this year, however we do not have knowledge of the availability of these alternatives. It is recommended to check with your relevant pharmacy to clarify supply options when prescribing.
Last modified: